SR ONE CAPITAL MANAGEMENT, LP Q3 2023 Filing

Filed November 13, 2023

Portfolio Value

$195.1B

Holdings

6

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
ACLXARCELLX INC.
3,946,630$141.6B72.57%
2
MLYSMINERALYS THERAPEUTICS
1,794,600$17.1B8.75%
3
DSGNDESIGN THERAPEUTICS INC
6,526,476$15.4B7.89%
4
SPRYARS PHARMACEUTICALS
4,012,903$15.2B7.77%
5
EFTREFFECTOR THERAPEUTICS INC
6,822,114$4.0B2.06%
6
NKTXNKARTA INC.
1,333,333$1.9B0.95%